Donald Trump urged to target ‘lazy patent expansion’ in US drug bill push
[ad_1] Unlock the White House Watch newsletter for free Your guide to what Trump’s second term means for Washington, business and the world The chief
Day 1 after diabetes drug Empagliflozin goes off patent, generics go to town with it
[ad_1] Drugmakers have begun to roll-out their generic versions of diabetes drug Empagliflozin – on day one after the innovative drug from Boehringer Ingelheim (BI)
